Astrana Health (ASTH) Current Deferred Revenue (2023 - 2025)

Astrana Health has disclosed Current Deferred Revenue across 3 years of filings, most recently posting $2.7 million for Q4 2025.

• Current Deferred Revenue for Q4 2025 came in at $2.7 million, up 65.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.7 million (up 65.57% YoY), and the FY2025 annual result was $2.7 million, up 65.57% from the prior year.
• Current Deferred Revenue came in at $2.7 million for Q4 2025 at Astrana Health, up from $686000.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $2.7 million in Q4 2025 to a low of $686000.0 in Q1 2025.
• The 3-year median for Current Deferred Revenue is $1.9 million (2024), against an average of $1.8 million.
• Across the five-year window, Current Deferred Revenue surged 115.86% in 2024 and jumped 65.57% in 2025, its largest moves.
• Astrana Health's Current Deferred Revenue stood at $744000.0 in 2023, then soared by 115.86% to $1.6 million in 2024, then surged by 65.57% to $2.7 million in 2025.
• The last three Current Deferred Revenue figures came in at $2.7 million (Q4 2025), $686000.0 (Q1 2025), and $1.6 million (Q4 2024), per Business Quant data.